GlassScriptPhysician profile
Trang M Pham
NPI 1083606081
$4,046.33
in general payments reported to CMS, 2019-2025
40 companies · $821 in 2025
The $821 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $176 · 2021: $339 · 2022: $796 · 2023: $682 · 2024: $664 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,166.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $485.08 | 2019-2025 | |
| Novo Nordisk INC | $323.86 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $304.87 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $298.62 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $292.87 | 2019-2025 | Airsupra, Fasenra, Farxiga |
| Merck Sharp & Dohme LLC | $238.33 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Glaxosmithkline, LLC. | $197.02 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $165.07 | 2019-2024 | Evenity, Prolia |
| Abbott Laboratories | $153.14 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Corium, LLC | $150.96 | 2022-2024 | Azstarys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.05 | 2020-2025 | Jardiance |
| Lundbeck LLC | $127.59 | 2022-2025 | Vyepti, Rexulti |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | Libtayo |
| Janssen Pharmaceuticals, INC | $81.15 | 2020-2023 | Xarelto |
| Dexcom, INC. | $75.38 | 2024-2025 | Dexcom G6 Transmitter |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trang Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.